After clinicians successfully deal with an acute ischemic stroke, they still face the ongoing challenge of managing a patient facing a high risk of stroke recurrence. See-Mode Technologies is developing AI-enabled software that can detect, on routine ultrasound, CT and MR images, risk factors normally only detectable by advanced imaging modalities.Subscribe now to read the full analysis
Welcome to MyStrategist, an online experience like no other in the medical device industry.
With MyStrategist, quickly uncover the breadth and depth of the editorial offerings found only in MedTech Strategist and MedTech Strategist Market Pathways – now on an all-in-one, digital platform. We invite you to explore our coverage.
Think Strategically. Subscribe Today.
Discover the opportunities and challenges that impact the global medtech regulatory and reimbursement community with MedTech Strategist Market Pathways.Subscribe Free Premier Issue Learn More
Welcome to the October 10 edition of Pathways’ Picks, MTS Market Pathways’ weekly roundup of the most important global medtech regulatory, reimbursement, and policy news. This week: the Trump administration tries to add legal clarity for value-based contracts, the first notified body is designated for the EU IVD Regulation, updates from China and India agencies, dates to remember, and more.Subscribe now to read the full analysis
Innovation Summit San Francisco, November 18-19th, is coming soon. Early-bird registration expires Oct. 31st!Register Learn More
MedTech Strategist speaks with Katie Ellias, Managing Director of JDRF’s T1D Fund, which aims to bring innovative new solutions to the treatment of type 1 diabetes.Subscribe now to read the full analysis